Cancer-directed surgery in malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication  

作　　者：Brian Housman Andrea S.Wolf 

机构地区：[1]Department of Thoracic Surgery,Icahn School of Medicine at Mount Sinai,New York 10029,USA.

出　　处：《Journal of Cancer Metastasis and Treatment》2021年第1期938-949,共12页癌症转移与治疗（英文版）

摘　　要：Malignant pleural mesothelioma(MPM)is a primary solid malignancy related to inhalational asbestos exposure.Despite advances in therapy,MPM remains challenging to treat with a post-treatment survival of only 15%at 5-year.In recent years,extra-pleural pneumonectomy has decreased in popularity due to a high morbidity rate and mortality compared to pleurectomy/decortication and other therapeutic alternatives.In this review,we will discuss both procedures,outcomes,ongoing studies,and the roles of surgery in the future treatment of this disease.

关 键 词：Surgery for malignant pleural mesothelioma extrapleural pneumonectomy pleurectomy/decortication recurrence perioperative mortality 

分 类 号：R73[医药卫生—肿瘤]